The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis
Open accessThe DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
Epithelial–stromal interactions play a critical role in tumor initiation and progression; cancer-associated stroma, but not normal stroma, is known to be tumor-promoting. However, the molecular signal used by epithelial cancer cells to reprogram normal stroma to a tumorigenic stroma is not known. Here, we present evidence to suggest that the chemokine growth-regulated oncogene 1 (Gro-1) may be one such signaling molecule. We showed that the expression of Gro-1 is activated by RAS and is vital for cell survival and the malignant transformation of ovarian epithelial cells. Surprisingly, we found that Gro-1 is a potent inducer of senescence in stromal fibroblasts and that this effect depends on functional p53. Senescent fibroblasts induced by Gro-1 can promote tumor growth whereas abrogation of senescence through immortalization results in loss of such tumor promoting activity. We also demonstrated that stromal fibroblasts adjacent to epithelial cancer cells are senescent in human ovarian cancer specimens and in heterografts from RAS-transformed human ovarian epithelial cells and ovarian cancer cells. Moreover, Gro-1 was expressed at significantly higher amounts in ovarian cancer than in normal tissues and was higher in serum samples from women with ovarian cancer than in serum from women without ovarian cancer. These findings provide strong evidence that RAS-induced Gro-1 can reprogram the stromal microenvironment through the induction of senescence of fibroblasts and thus can promote tumorigenesis. Therefore, Gro-1 may be a therapeutic target as well as a diagnostic marker in ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other SASP factors implicated in stimulating tumor cell growth are amphiregulin and the GROs (94–96), but there are a plethora of other candidates.”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [95]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Likewise, GROα, a potent mitogen that is a SASP component and is induced by oncogenic RAS, promotes the senescence of normal human ovarian fibroblasts (95).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [95]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Thus, oncogenes such as RAS, which are known to activate protumorigenic paracrine mechanisms during transformation [ 59 – 61 ], might also exert cell-nonautonomous protumorigenic effects through nontransformed cells during the process of inducing senescence ( Figure 7 D).”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [60]
The cited source says what the claim attributes to it.
In the citing paper
“the chemokine GRO1 (also known as CXCL1), which is secreted from transformed cells, can induce senescence in stromal fibroblasts 125”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Friends or foes — bipolar effects of the tumour stroma in cancer
Mueller, M. M., & Fusenig, N. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1477 · Cited by 1,765
Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Research works printed but not linked: 11
- AF Olumi, GD Grossfeld, SW Hayward, PR Carroll, TD Tlsty, GR Cunha Cancer Res 59, 5002–5011 (1999).
- E Balentien, BE Mufson, RL Shattuck, R Derynck, A Richmond Oncogene 6, 1115–1124 (1991).
- IM Shih, M Herlyn In Vivo 8, 113–123 (1994).
- Yang G, Rosen DG, Mercado-Uribe I, Colacino JA, Mills GB, Bast RC, Jr, Zhou C, Liu J (July 8, 2006) Carcinogenesis , 10.1093 ∕ carcin ∕ bgl115.
- Mok SC, Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, Berkowitz RS, Tsao SW (1993) Cancer Res 53:1489-1492.
- Ichikawa Y, Nishida M, Suzuki H, Yoshida S, Tsunoda H, Kubo T, Uchida K, Miwa M (1994) Cancer Res 54:33-35.
- Cuatrecasas M, Villanueva A, Matias-Guiu X, Prat J (1997) Cancer 79:1581-1586. · doi:10.1002/(sici)1097-0142(19970415)79:8<1581::aid-cncr21>3.0.co;2-t
- Cuatrecasas M, Erill N, Musulen E, Costa I, Matias-Guiu X, Prat J (1998) Cancer 82:1088-1095. · doi:10.1002/(sici)1097-0142(19980315)82:6<1088::aid-cncr12>3.0.co;2-2
- Bosman FT, de Bruine A, Flohil C, van der Wurff A, ten Kate J, Dinjens WW (1993) Int J Dev Biol 37:203-211.
- Krtolica A, Campisi J (2003) Adv Gerontol 11:109-116.
- Kacinski BM (1995) EXS 74:181-190.
Cited by
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
“Likewise, GROα, a potent mitogen that is a SASP component and is induced by oncogenic RAS, promotes the senescence of normal human ovarian fibroblasts (95).”
BackgroundThe role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Shibue, T., & Weinberg, R. A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.44 · Cited by 2,539
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
“For example, signaling through the IL-6 and IL-8 (CXCR2) receptors is essential, in a cellautonomous fashion, for cells to enter senescence in response to oncogenic BRAF or replicative exhaustion, respectively (Acosta et al. 2008; Kuilman et al. 2008).”
BackgroundInfluentialTranscriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921
“The introduction of an activated RAS oncogene into a normal cell results in p53-mediated senescenc”
BackgroundThe biology of ovarian cancer: new opportunities for translation
Bast, R. C., Hennessy, B., & Mills, G. B. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2644 · Cited by 1,358
Self-citationInflammatory networks during cellular senescence: causes and consequences.
Freund, A., Orjalo, A. V., Desprez, P.-Y., & Campisi, J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.03.003 · Cited by 1,354
Senescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284
Cellular senescence: the good, the bad and the unknown
Huang, W., Hickson, L. J., Eirin, A., Kirkland, J. L., & Lerman, L. O. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00601-z · Cited by 1,150
Fibroblast heterogeneity in the cancer wound
Öhlund, D., Elyada, E., & Tuveson, D. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140692 · Cited by 926
Senescence-messaging secretome: SMS-ing cellular stress
Kuilman, T., & Peeper, D. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2560 · Cited by 909
Kojima, Y., Acar, A., Eaton, E. N., Mellody, K. T., Scheel, C., Ben-Porath, I., Onder, T. T., Wang, Z. C., Richardson, A. L., Weinberg, R. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013805107 · Cited by 848
Exploiting senescence for the treatment of cancer
Wang, L., Lankhorst, L., & Bernards, R. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00450-9 · Cited by 867
Stromal myofibroblasts are drivers of invasive cancer growth
De Wever, O., Demetter, P., Mareel, M., & Bracke, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23925 · Cited by 722
The senescence-associated secretory phenotype and its regulation
Lopes-Paciencia, S., Saint-Germain, E., Rowell, M.-C., Ruiz, A. F., Kalegari, P., & Ferbeyre, G. (2019) · Cytokine · doi:10.1016/j.cyto.2019.01.013 · Cited by 601
Homeostatic chemokine receptors and organ-specific metastasis
Zlotnik, A., Burkhardt, A. M., & Homey, B. (2011) · Nature Reviews Immunology · doi:10.1038/nri3049 · Cited by 571
“EGFR-induced RAS activation leads to increased expression of CXCL8 and CXCL1 by tumour cell”
BackgroundRole of chemokines in tumor growth
Raman, D., Baugher, P. J., Thu, Y. M., & Richmond, A. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.05.013 · Cited by 578
Renal Aging: Causes and Consequences
O’Sullivan, E. D., Hughes, J., & Ferenbach, D. A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015121308 · Cited by 484
Inside and out: the activities of senescence in cancer
Pérez-Mancera, P. A., Young, A. R. J., & Narita, M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3773 · Cited by 462
Coppé, J.-P., Patil, C. K., Rodier, F., Krtolica, A., Beauséjour, C. M., Parrinello, S., Hodgson, J. G., Chin, K., Desprez, P.-Y., & Campisi, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009188 · Cited by 455
“This potent epithelial growth factor has also been shown to induce or reinforce the senescence growth arrest [50], similar to recently reported activities of the SASP factors IL-6 and IL-8 [28,30].”
ResultIannello, A., Thompson, T. W., Ardolino, M., Lowe, S. W., & Raulet, D. H. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130783 · Cited by 414
The fate of chemoresistance in triple negative breast cancer (TNBC)
O’Reilly, E. A., Gubbins, L., Sharma, S., Tully, R., Guang, M. H. Z., Weiner-Gorzel, K., McCaffrey, J., Harrison, M., Furlong, F., Kell, M., et al. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.03.003 · Cited by 377
“38 senescent [185] suggesting a possible role for their assessment in identifying tumour free margins.”
BackgroundPotential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
Cheng, Y., Ma, X.-L., Wei, Y.-Q., & Wei, X.-W. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.01.005 · Cited by 344
Transcriptomic dissection of tongue squamous cell carcinoma
Ye, H., Yu, T., Temam, S., Ziober, B. L., Wang, J., Schwartz, J. L., Mao, L., Wong, D. T., & Zhou, X. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-69 · Cited by 344
“CXCL1, also known as growth-regulated oncogene 1 (Gro-1), is vital for the survival, progression and invasion of several cancer types [18,19], including oral cancer [20].”
BackgroundThe role of reactive oxygen species and metabolism on cancer cells and their microenvironment
Costa, A., Scholer-Dahirel, A., & Mechta-Grigoriou, F. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.007 · Cited by 324
“Indeed, CAFs exhibit higher tumor-prone potential compared to their normal counterparts [25,44,67,87–92].”
BackgroundCellular senescence in renal ageing and disease
Sturmlechner, I., Durik, M., Sieben, C. J., Baker, D. J., & van Deursen, J. M. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.183 · Cited by 345
Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression
Shimoda, M., Mellody, K. T., & Orimo, A. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.10.002 · Cited by 325
Stromal Cells in the Tumor Microenvironment
Denton, A. E., Roberts, E. W., & Fearon, D. T. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-78127-3_6 · Cited by 306
Brennen, W. N., Isaacs, J. T., & Denmeade, S. R. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0340 · Cited by 289
Coppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302
“Thus, oncogenes such as RAS, which are known to activate protumorigenic paracrine mechanisms during transformation [59–61], might also exert cell-nonautonomous protumorigenic effects through nontransformed cells during the process of inducing senescence (Figure 7D).”
BackgroundEmerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence
Xu, Y., Li, N., Xiang, R., & Sun, P. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.04.004 · Cited by 282
Niu, N., Mercado-Uribe, I., & Liu, J. (2017) · Oncogene · doi:10.1038/onc.2017.72 · Cited by 265
Self-citationZhang, Y., Tang, H., Cai, J., Zhang, T., Guo, J., Feng, D., & Wang, Z. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.01.011 · Cited by 242
“There are also studies reported that senescent fibroblasts induced by Gro-1 can promote tumor growth in vitro [7].”
BackgroundMalaquin, N., Martinez, A., & Rodier, F. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.05.010 · Cited by 247
“…of premalignant and cancer cells by promoting tumour growth, an epithelial-to-mesenchymal transition (EMT), and migration and invasion (Krtolica et al., 2001; Liu and Hornsby, 2007; Sun et al., 2012; Yang et al., 2006) (Malaquin et al., 2013) (Bavik et al., 2006; Parrinello et al., 2005).”
Augsten, M., Hägglöf, C., Olsson, E., Stolz, C., Tsagozis, P., Levchenko, T., Frederick, M. J., Borg, Å., Micke, P., Egevad, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813144106 · Cited by 242
“Furthermore, CAFs of ovarian cancer over-express the chemokine CXCL1/GRO1 (11).”
BackgroundCell Senescence: Role in Aging and Age-Related Diseases
Campisi, J., & Robert, L. (2014) · Interdisciplinary Topics in Gerontology and Geriatrics · doi:10.1159/000358899 · Cited by 240
Wang, Z., Zhang, X., Fang, C., Liu, X., Liao, Q., Wu, N., & Wang, J. (2024) · Immunology · doi:10.1111/imm.13793 · Cited by 204
“Gro-1 could potentially be a treatment target and diagnostic bio-marker for OC, as reprogramming the stromal microenvironment through the induction of fibroblast aging by ras-stimulated Gro-1 can enhance tumorigenesis [136].”
Studebaker, A. W., Storci, G., Werbeck, J. L., Sansone, P., Sasser, A. K., Tavolari, S., Huang, T., Chan, M. W. Y., Marini, F. C., Rosol, T. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0400 · Cited by 229
James, E. L., Michalek, R. D., Pitiyage, G. N., de Castro, A. M., Vignola, K. S., Jones, J., Mohney, R. P., Karoly, E. D., Prime, S. S., & Parkinson, E. K. (2015) · Journal of Proteome Research · doi:10.1021/pr501221g · Cited by 231
Two-Step Senescence-Focused Cancer Therapies
Sieben, C. J., Sturmlechner, I., van de Sluis, B., & van Deursen, J. M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.04.006 · Cited by 222
Caveolae and signalling in cancer
Martinez-Outschoorn, U. E., Sotgia, F., & Lisanti, M. P. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3915 · Cited by 211
Carcinoma‐associated fibroblasts: Non‐neoplastic tumour‐promoting mesenchymal cells
Polanska, U. M., & Orimo, A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24347 · Cited by 208
Tumor stroma as targets for cancer therapy
Zhang, J., & Liu, J. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.10.003 · Cited by 187
“Our laboratory also has determined that another stromal-activating chemokine, growth-regulated oncogene-α-overexpressing ovarian fibroblasts with inhibited p53, can significantly increase ovarian cancer cell proliferation and tumorigenic growth in a mouse xenograft model (Yang et al., 2006).”
BackgroundSelf-citationThibault, B., Castells, M., Delord, J.-P., & Couderc, B. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9456-2 · Cited by 184
“This transformation could be initiated by growth-regulated oncogene 1 (GRO-1) whose expression is activated in Ras-transformed human ovarian epithelial cells and ovarian cancer cells [144].”
BackgroundBreast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go
Buchsbaum, R., & Oh, S. (2016) · Cancers · doi:10.3390/cancers8020019 · Cited by 183
“Several studies have demonstrated that senescent fibroblasts contribute to tumor development [88–90].”
BackgroundYang, G., Rosen, D. G., Liu, G., Yang, F., Guo, X., Xiao, X., Xue, F., Mercado-Uribe, I., Huang, J., Lin, S.-H., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0483 · Cited by 183
“Transformation of immortalized ovarian surface epithelial cells (T29), which express SV40 T/t antigens and human telomerase catalytic subunit, by Gro-1 or HRAS also induced the up-regulation of CXCR2 (4, 23).”
BackgroundMethodInfluentialSelf-citationLessons from patient-derived xenografts for better in vitro modeling of human cancer
Choi, S. Y. C., Lin, D., Gout, P. W., Collins, C. C., Xu, Y., & Wang, Y. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.009 · Cited by 177
“blasts [105–111].”
Osteopontin at the Crossroads of Inflammation and Tumor Progression
Castello, L. M., Raineri, D., Salmi, L., Clemente, N., Vaschetto, R., Quaglia, M., Garzaro, M., Gentilli, S., Navalesi, P., Cantaluppi, V., et al. (2017) · Mediators of Inflammation · doi:10.1155/2017/4049098 · Cited by 170
CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer
Korbecki, J., Kupnicka, P., Chlubek, M., Gorący, J., Gutowska, I., & Baranowska-Bosiacka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042168 · Cited by 165
“In the absence of CXCR2 activation on CAFs, these cells become myofibroblasts [134].”
BackgroundWeiner‐Gorzel, K., Dempsey, E., Milewska, M., McGoldrick, A., Toh, V., Walsh, A., Lindsay, S., Gubbins, L., Cannon, A., Sharpe, D., et al. (2015) · Cancer Medicine · doi:10.1002/cam4.409 · Cited by 166
“Yang and colleagues demonstrated that coinjection of senescent ovarian fibroblasts with premalignant epithelial cells into mice induced progression of senescence-dependent carcinogenesis in vivo [47].”
BackgroundSchauer, I. G., Sood, A. K., Mok, S., & Liu, J. (2011) · Neoplasia · doi:10.1593/neo.101720 · Cited by 155
“Furthermore, we have used our Ras-mediated ovarian cancer mouse xenograft model to demonstrate that GRO-α– expressing senescent ovarian fibroblasts significantly promoted xenograft tumorigenesis of preneoplastic ovarian surface epithelial cells [63].”
BackgroundMethodInfluentialSelf-citationMacrophage Infiltration Predicts a Poor Prognosis for Human Ewing Sarcoma
Fujiwara, T., Fukushi, J.-I., Yamamoto, S., Matsumoto, Y., Setsu, N., Oda, Y., Yamada, H., Okada, S., Watari, K., Ono, M., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.05.034 · Cited by 164
The role of cellular senescence in skin aging and age-related skin pathologies
Chin, T., Lee, X. E., Ng, P. Y., Lee, Y., & Dreesen, O. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1297637 · Cited by 138
Carcinoma-Associated Fibroblasts Are a Promising Therapeutic Target
Togo, S., Polanska, U., Horimoto, Y., & Orimo, A. (2013) · Cancers · doi:10.3390/cancers5010149 · Cited by 156
“In addition to the ability of CAFs to promote neoangiogenesis and tumour growth [23–28], recent reports have indicated emerging roles for these cells in the modulation of cancer stem cell (CSC) traits and in the formation of metastases [29–32].”
BackgroundInflammatory signaling and cellular senescence
Ren, J.-L., Pan, J.-S., Lu, Y.-P., Sun, P., & Han, J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.011 · Cited by 148
The role of exosomes and microRNAs in senescence and aging
Xu, D., & Tahara, H. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.010 · Cited by 162
Senescent Stromal-Derived Osteopontin Promotes Preneoplastic Cell Growth
Pazolli, E., Luo, X., Brehm, S., Carbery, K., Chung, J.-J., Prior, J. L., Doherty, J., Demehri, S., Salavaggione, L., Piwnica-Worms, D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2970 · Cited by 147
“Indeed, the presence of senescent cells increases with age (15–17) and these cells possess the capacity to promote preneoplastic cell growth in several models (19, 20, 27, 28).”
Heterogeneity of stromal fibroblasts in tumor
Orimo, A., & Weinberg, R. A. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.4.4255 · Cited by 143
“Another example of the heterogeneity of stromal fibroblasts is provided by a subpopulation of SA--gal-positive, senescent fibroblast populations that are present among the stromal fibroblasts in human ovarian carcinomas; these senescent fibroblasts play pivotal roles in enhancing carcinogenesis through paracrine signa…”
BackgroundZhang, X., Qi, Z., Yin, H., & Yang, G. S. (2019) · Theranostics · doi:10.7150/thno.29673 · Cited by 160
“Immunofluorescence (IF) staining was performed as described previously [22].”
MethodSelf-citationThe role of cellular senescence and SASP in tumour microenvironment
Takasugi, M., Yoshida, Y., Hara, E., & Ohtani, N. (2023) · The FEBS Journal · doi:10.1111/febs.16381 · Cited by 144
Gandellini, P., Andriani, F., Merlino, G., D’Aiuto, F., Roz, L., & Callari, M. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.08.008 · Cited by 149
Yang, L., Zhou, Y., Li, Y., Zhou, J., Wu, Y., Cui, Y., Yang, G. S., & Hong, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.003 · Cited by 147
Self-citationStolze, B., Reinhart, S., Bulllinger, L., Fröhling, S., & Scholl, C. (2015) · Scientific Reports · doi:10.1038/srep08535 · Cited by 130
Ovarian cancer: pathology, biology, and disease models
Daniel, G. R. (2009) · Frontiers in bioscience · doi:10.2741/3364 · Cited by 154
“In a previous study, we used three senescence markers (SA-β-gal, p16, and H1B-β and found that fibroblasts near epithelial ovarian cancer cells are senescent (87).”
MethodThe roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas
Mezawa, Y., & Orimo, A. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2471-1 · Cited by 138
“CAFs include particular cell populations that undergo senescence (Alspach et al. 2014; Yang et al. 2006).”
BackgroundYang, G., Chang, B., Yang, F., Guo, X., Cai, K. Q., Xiao, X. (., Wang, H., Sen, S., Hung, M.-C., Mills, G. B., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3171 · Cited by 124
Self-citationOverexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer
Cheng, W.-P., Wang, C. S., Huang, Y., Tsai, M.-M., Liang, Y. J., & Lin, K. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq739 · Cited by 136
“In addition, overexpression of CXCL1 has been reported in a series of human cancers [8, 9, 23].”
BackgroundBolitho, C., Hahn, M. A., Baxter, R. C., & Marsh, D. J. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0107 · Cited by 137
“Since both in vitro (Moscova et al. 2006) and in vivo (Lee et al. 2006, Yang et al. 2006, Wang et al. 2008) studies suggest a role for CXCL1 in EOC, our findings point to potential therapeutic targets for this disease.”
BackgroundInfluentialRoles and mechanisms of cellular senescence in regulation of tissue homeostasis
Ohtani, N., & Hara, E. (2013) · Cancer Science · doi:10.1111/cas.12118 · Cited by 119
Stanniocalcin 1 and Ovarian Tumorigenesis
Liu, G., Yang, G., Chang, B., Mercado-Uribe, I., Huang, M., Zheng, J., Bast, R. C., Lin, S.-H., & Liu, J. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq127 · Cited by 118
“T29-STC1 and T80-STC1 cells and their corresponding control cells were used for analysis of epithelial ovarian cancer marker CA 125 by immunofluorescence staining as described previously (30).”
MethodSelf-citationSenescent stroma promotes prostate cancer progression: The role of miR‐210
Taddei, M. L., Cavallini, L., Comito, G., Giannoni, E., Folini, M., Marini, A., Gandellini, P., Morandi, A., Pintus, G., Raspollini, M. R., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.009 · Cited by 119
“Similar results were obtained also by Yang et al., in human ovarian cancer where stromal fibroblasts adjacent to epithelial cancer cells (and possibly tumor-educated/activated), are senescent (Yang et al., 2006).”
BackgroundResultThe “life code”: A theory that unifies the human life cycle and the origin of human tumors
Liu, J. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.005 · Cited by 126
Self-citationFan, G., Yu, B., Tang, L., Zhu, R., Chen, J., Zhu, Y., Huang, H., Zhou, L., Liu, J., Wang, W., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adj5705 · Cited by 128
“Several studies have demonstrated that regions adjacent to the cancer epithelium are preferentially enriched with senescent stromal cells ( 23 , 24 ).”
BackgroundSelf-citationAgarwal, A., Tressel, S. L., Kaimal, R., Balla, M., Lam, F. H., Covic, L., & Kuliopulos, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4341 · Cited by 119
“Moreover, GRO-α is expressed at higher levels in the tissue and serum of patients with ovarian cancer as compared with normal women (15).”
Han, X., Lin, F., Wang, Z., Yang, L., Meng, J., Ou, Z., Shao, Z., Di, G., & Yang, G. S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.030 · Cited by 118
Self-citationHassona, Y., Cirillo, N., Lim, K. P., Herman, A., Mellone, M., Thomas, G. J., Pitiyage, G. N., Parkinson, E. K., & Prime, S. S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt035 · Cited by 110
“In addition, Gro-1α from ovarian epithelial cells has been reported to induce senescence in ovarian fibroblasts (44).”
BackgroundInfluentialMicroRegulators come of age in senescence
Gorospe, M., & Abdelmohsen, K. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.03.005 · Cited by 108
Senescent Fibroblasts Enhance Early Skin Carcinogenic Events via a Paracrine MMP-PAR-1 Axis
Malaquin, N., Vercamer, C., Bouali, F., Martien, S., Deruy, E., Wernert, N., Chwastyniak, M., Pinet, F., Abbadie, C., & Pourtier, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063607 · Cited by 101
“Yet fibroblast senescence may contribute to promoting cancer development and evolution, in a non-cell-autonomous, paracrine way, as suggested by the observation that senescent fibroblasts can stimulate growth, the epithelial-mesenchymal transition (EMT), and invasiveness of premalignant and malignant cells [7,10,11,12…”
Backgroundp53 Status in Stromal Fibroblasts Modulates Tumor Growth in an SDF1-Dependent Manner
Addadi, Y., Moskovits, N., Granot, D., Lozano, G., Carmi, Y., Apte, R. N., Neeman, M., & Oren, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1146 · Cited by 108
“5C and Supplementary Fig 3B), known to be associated with tumorigenesis [42-44].”
BackgroundControl of senescence by CXCR2 and its ligands
Acosta, J. C., Loghlen, A., Banito, A., Raguz, S., & Gil, J. (2008) · Cell Cycle · doi:10.4161/cc.7.19.6780 · Cited by 106
Liu, Y., Hawkins, O. E., Su, Y., Vilgelm, A. E., Sobolik, T., Thu, Y., Kantrow, S., Splittgerber, R. C., Short, S., Amiri, K. I., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201378 · Cited by 99
“Due to the production of specific growth factors, senescent fibroblasts can induce premalignant and malignant epithelial cells to proliferate in vitro , potentially contributing to tumour formation in aged organisms (Krtolica et al, 2001; Yang et al, 2006a).”
Schauer, I. G., Zhang, J., Xing, Z., Guo, X., Mercado-Uribe, I., Sood, A. K., Huang, P., & Liu, J. (2013) · Neoplasia · doi:10.1593/neo.121228 · Cited by 97
“[24] Yang G, Rosen DG, Zhang Z, Bast RC Jr, Mills GB, Colacino JA, Mercado-”
BackgroundMethodSelf-citationCellular senescence and tumor promotion: Is aging the key?
Loaiza, N., & Demaria, M. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.01.007 · Cited by 101
Zhang, Z., Gao, Z., Rajthala, S., Sapkota, D., Dongre, H., Parajuli, H., Suliman, S., Das, R., Li, L., Bindoff, L. A., et al. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03209-y · Cited by 107
Self-citationTumor-Derived CXCL1 Promotes Lung Cancer Growth via Recruitment of Tumor-Associated Neutrophils
Yuan, M., Zhu, H., Xu, J., Zheng, Y., Cao, X., & Liu, Q. (2016) · Journal of Immunology Research · doi:10.1155/2016/6530410 · Cited by 98
“Elevated levels of CXCL1 and CXCR2 positively correlate with the poorer prognosis of cancer patients [12, 13].”
Patel, A. K., Vipparthi, K., Thatikonda, V., Arun, I., Bhattacharjee, S., Sharan, R., Arun, P., & Singh, S. (2018) · Oncogenesis · doi:10.1038/s41389-018-0087-x · Cited by 93
Bonafè, M., Storci, G., & Franceschi, C. (2012) · BioEssays · doi:10.1002/bies.201100104 · Cited by 94
“Nevertheless, similar alterations occur in stromal fibroblasts adjacent to cancer cells that over-produce inflammatory cytokines [15, 67].”
Wei, Z.-W., Xia, G., Wu, Y., Chen, W., Xiang, Z., Schwarz, R. E., Brekken, R. A., Awasthi, N., He, Y.-L., & Zhang, C.-H. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.033 · Cited by 98
FGF18 as a prognostic and therapeutic biomarker in ovarian cancer
Wei, W., Mok, S. C., Oliva, E., Kim, S., Mohapatra, G., & Birrer, M. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70625 · Cited by 95
“In fact, recent studies have demonstrated that FGF18-related proinflammatory cytokines and chemokines, such as CXCL1, are capable of transforming tumor-associated fibroblasts to a “senescence associated secretory phenotype,” which in turn becomes another important source of soluble factors for tumor growth, metastasis…”
Cellular senescence in cancer: clinical detection and prognostic implications
Domen, A., Deben, C., Verswyvel, J., Flieswasser, T., Prenen, H., Peeters, M., Lardon, F., & Wouters, A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02555-3 · Cited by 94
“In contrast, identification of senescent cancer-associated fibroblasts (CAFs) adjacent to epithelial ovarian cancer cells in ovarian cancer specimens were suggested to promote ovarian cancer tumorigenesis [161].”
BackgroundKorbecki, J., Gąssowska-Dobrowolska, M., Wójcik, J., Szatkowska, I., Barczak, K., Chlubek, M., & Baranowska‐Bosiacka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084205 · Cited by 99
Kitano, H., Kageyama, S.-I., Hewitt, S. M., Hayashi, R., Doki, Y., Ozaki, Y., Fujino, S., Takikita, M., Kubo, H., & Fukuoka, J. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2009-0114-oa.1 · Cited by 92
Lawrenson, K., Grun, B., Benjamin, E., Jacobs, I. J., Dafou, D., & Gayther, S. A. (2010) · Neoplasia · doi:10.1593/neo.91948 · Cited by 90
“Support for this hypothesis has come from the analysis of human ovarian tumors, which have been shown to contain a large number of senescent fibroblasts within the tumor stroma; this may also suggest a role for senescent fibroblasts in the maintenance of ovarian tumors [32].”
BackgroundOncogenic Ras-Induced Expression of Cytokines: A New Target of Anti-Cancer Therapeutics
Ancrile, B. B., O'Hayer, K. M., & Counter, C. M. (2008) · Molecular Interventions · doi:10.1124/mi.8.1.6 · Cited by 92
Okumura, T., Ericksen, R. E., Takaishi, S., Wang, S. S. W., Dubeykovskiy, Z., Shibata, W., Betz, K. S., Muthupalani, S., Rogers, A. B., Fox, J. G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1506 · Cited by 95
“The chemokine CXCL1 is overexpressed in human gastric cancers (37), and is a known critical downstream mediator of mutant Ras that recruits neutrophils (38), supports angiogenesis (39), regulates the microenvironment (35), and directly promotes tumorigenesis (39).”
BackgroundJunnila, S., Kokkola, A., Mizuguchi, T., Hirata, K., Karjalainen‐Lindsberg, M., Puolakkainen, P. A., & Monni, O. M. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20715 · Cited by 101
“This gene has also been reported to be over-expressed in bladder and ovarian carcinomas (Kawanishi et al., 2008; Yang et al., 2006) but over-expression of CXCL1 in gastric cancers compared with the nonmalignant tissue has not been previously reported.”
ResultFrom cancer immunosurveillance to cancer immunotherapy
Stagg, J., Johnstone, R. W., & Smyth, M. J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00566.x · Cited by 107
The Biphasic Role of NF-κB in Progression and Chemoresistance of Ovarian Cancer
Yang, G. S., Xiao, X., Rosen, D. G., Cheng, X., Wu, X., Chang, B., Liu, G., Xue, F., Mercado‐Uribe, I., Chiao, P. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3265 · Cited by 93
“Retroviral production and infection The protocol for retroviral production and infection to establish the following virus-containing cell lines was carried out as described previously (36): SKOV3/vector, HEY/ vector, SKOV3/IkBaM, HEY/IkBaM; SKOV3.”
MethodSelf-citationYin, H., Wang, J., Li, H. Z., Yu, Y., Wang, X., Lu, L., Lv, C., Chang, B., Jin, W., Guo, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24315-1 · Cited by 81
Self-citationSenescent Peritoneal Mesothelial Cells Promote Ovarian Cancer Cell Adhesion
Książek, K., Mikuła‐Pietrasik, J., Korybalska, K., Dworacki, G., Jörres, A., & Witowski, J. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080613 · Cited by 85
Metadata
- Authors
- Yang, G., Rosen, D. G., Zhang, Z., Bast, R. C., Mills, G. B., Colacino, J. A., Mercado-Uribe, I., & Liu, J.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Experimental Therapeutics, and
- Departments of *Pathology,
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-10-31
- Volume
- 103
- Issue
- 44
- Pages
- 16472-16477
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1637606
- OpenAlex
- W1992742879
- Cited by
- 341
- References
- 49
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 19 · 2023: 23 · 2022: 15 · 2021: 12 · 2020: 15 · 2019: 16 · 2018: 19 · 2017: 9 · 2016: 28 · 2015: 26 · 2014: 23 · 2013: 26 · 2012: 12
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- Ras signaling, cellular senescence, stromal fibroblasts, ovarian cancer, stromal-epithelial interactions, cancer-associated stroma, p53, tumor microenvironment, malignant transformation, tumor growth promotion, serum biomarkers, therapeutic target
- MeSH terms
- Cell Transformation, Neoplastic, Cells, Cultured, Female, Fibroblasts, Gene Expression Regulation, Humans, Ovarian Neoplasms, Signal Transduction, Biomarkers, Tumor Suppressor Protein p53, Cellular Senescence, Stromal Cells, Apoptosis, ras Proteins, Chemokines, CXC, Chemokine CXCL1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.